Women's Quality of Life, Sexual Life and Psychological State in Patients Undergoing Embryo Transfers

NCT ID: NCT04131452

Last Updated: 2020-01-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

232 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-01-20

Study Completion Date

2020-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Women's quality of life, sexual life and psychological state would affect the success of embryo transfer. The primary purpose of the study is to compare women's quality of life, sexual life and psychological state using validated forms between those undergoing fresh embryo transfer and those undergoing frozen embryo transfer.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

There are two types of embryo transfers; fresh and frozen embryo transfers. Studies have been conducted to compare success rates between fresh and frozen embryo transfers. However, most studies have not taken into consideration women's quality of life, sexual life and psychological state in comparing fresh embryo transfer with frozen embryo transfers. These all parameters are confounding factors that may influence the success of embryo transfer. The purpose of this study is to compare women's quality of life, sexual life and psychological state using validated forms between those undergoing fresh embryo transfer and those undergoing frozen embryo transfer. The following forms will be used: expanded version of the inventory of depression and anxiety symptoms (IDAS-II), Beck Anxiety inventory (BAI), Short Form Survey (SF-36) and Female Sexual Function Index (FSFI. This study can provide evidence regarding the association between women's quality of life, sexual life and psychological state and embryo transfer success.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infertility, Female Anxiety State Depression Quality of Life Sexual Function and Fertility Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Fresh embryo transfers

those undergoing fresh embryo transfer

Filling out the forms including IDAS-II, BAI, SF-36 and FSFI

Intervention Type OTHER

Participants will fill out certain validated forms including the expanded version of the inventory of depression and anxiety symptoms (IDAS-II), Beck Anxiety inventory (BAI), Short Form Survey (SF-36) and Female Sexual Function Index (FSFI).

Frozen embryo transfers

those undergoing frozen embriyo transfer

Filling out the forms including IDAS-II, BAI, SF-36 and FSFI

Intervention Type OTHER

Participants will fill out certain validated forms including the expanded version of the inventory of depression and anxiety symptoms (IDAS-II), Beck Anxiety inventory (BAI), Short Form Survey (SF-36) and Female Sexual Function Index (FSFI).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Filling out the forms including IDAS-II, BAI, SF-36 and FSFI

Participants will fill out certain validated forms including the expanded version of the inventory of depression and anxiety symptoms (IDAS-II), Beck Anxiety inventory (BAI), Short Form Survey (SF-36) and Female Sexual Function Index (FSFI).

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age between 20 - 39 years
* Body mass index between 18 -3 5 kg/m2
* Anti-mullerian hormone levele \>1.1 ng/ml or antral follicle count \> 8
* fresh or frozen embryo transfer using middle-quality or good-quality day 3 or 5 embryos

Exclusion Criteria

* Age below 20 or over 39 years
* Uterine malformations
* Hypo or hyperthyroidism
* Diabetes mellitus
* Previous history of psychiatric disorders
* Use of psychiatric medications
* Systemic disorders (hypertension, chronic liver/kidney/heart problems)
Minimum Eligible Age

20 Years

Maximum Eligible Age

39 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Uskudar University

OTHER

Sponsor Role collaborator

Bahceci Health Group

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mehmet Resit Asoglu

Associate professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mehmet Resit Asoglu, Ass, prof

Role: PRINCIPAL_INVESTIGATOR

Bahceci Health Group

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bahceci Health Group

Istanbul, Sisli, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mehmet Resit Asoglu, Ass. Prof

Role: CONTACT

+90 530 923 83 16

Cem Celik, Prof

Role: CONTACT

+90 532 420 5365

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mehmet Resit Asoglu, Ass, prof

Role: primary

+90 530 923 83 16

Cem Celik, Prof

Role: backup

+90 532 420 53 65

References

Explore related publications, articles, or registry entries linked to this study.

Skvirsky V, Taubman-Ben-Ari O, Ben Shlomo S, Azuri J, Horowitz E. Contributors to Women's Perceived Stress at the Start of Assisted Reproductive Technology. J Psychol. 2019;153(1):23-36. doi: 10.1080/00223980.2018.1471037. Epub 2018 Sep 13.

Reference Type RESULT
PMID: 30211664 (View on PubMed)

Purewal S, Chapman SCE, van den Akker OBA. Depression and state anxiety scores during assisted reproductive treatment are associated with outcome: a meta-analysis. Reprod Biomed Online. 2018 Jun;36(6):646-657. doi: 10.1016/j.rbmo.2018.03.010. Epub 2018 Mar 23.

Reference Type RESULT
PMID: 29622404 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Bahceci Mehmet Asoglu

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Effect of Motivational Interviews
NCT06181890 ENROLLING_BY_INVITATION